Sector consensus Northwest Biotherapeutics, Inc. Börse Stuttgart

Stocks

Delayed Börse Stuttgart Other stock markets 10:33:32 2026-08-11 EDT			5-day change	1st Jan Change
0.1800 ^EUR	0.00%		+36.36%	-12.62%

08-06	Northwest Biotherapeutics and Saudi Pharmaceutical Industries and Medical Appliance Company Enter Memorandum of Understanding for Collaboration	CI
07-08	Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of Dcvax-L for Glioblastoma	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
WUXI APPTEC CO., LTD.	176.94	+9.67%	18
ARGENX SE	1,037.68	+17.12%	15
INSMED INCORPORATED	200.05	+48.46%	22
WUXI BIOLOGICS (CAYMAN) INC.	40.47	+2.01%	22
BIONTECH SE	104.26	+29.88%	20
GENMAB A/S	2,403.92	+20.68%	15
PHARMAESSENTIA CORPORATION	1,073.31	-19.3%	7
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	567.11	+7.31%	17
EXELIXIS, INC.	52.94	-0.04%	16
ARROWHEAD PHARMACEUTICALS, INC.	110.18	+24.74%	11
AKESO, INC.	145.4	+66.47%	20
MADRIGAL PHARMACEUTICALS, INC.	678.06	+31.58%	16
SUMMIT THERAPEUTICS INC.	21.06	+91.49%	13
CYTOKINETICS, INCORPORATED	108.85	+40.47%	20
REMEGEN CO., LTD.	100.13	+37.35%	15
SPYRE THERAPEUTICS, INC.	121.5	+15.35%	14
CRINETICS PHARMACEUTICALS, INC.	85.5	+1.6%	10
VAXCYTE, INC.	109	+87%	9
IMMUNITYBIO, INC.	12.75	+70.23%	4
Average	376.27	+30.63%	15
Weighted average by Cap.	453.19	+23.70%	16